Catalyst Pharmaceuticals, Inc. (CPRX)
23.23
-0.16
(-0.68%)
USD |
NASDAQ |
Mar 13, 16:00
23.22
-0.01
(-0.04%)
After-Hours: 20:00
Catalyst Pharmaceuticals Market Cap : 2.837B for March 13, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ANI Pharmaceuticals, Inc. | 1.580B |
| Assertio Holdings, Inc. | 74.05M |
| Ionis Pharmaceuticals, Inc. | 11.76B |
| Karyopharm Therapeutics, Inc. | 144.00M |
| Krystal Biotech, Inc. | 7.228B |
Market Cap Related Metrics
| PE Ratio | 13.79 |
| PS Ratio | 5.019 |
| PEG Ratio | 0.4804 |
| Price to Book Value | 2.973 |
| Price to Free Cash Flow | 14.17 |
| Price | 23.23 |
| Earnings Yield | 7.25% |
| PEGY Ratio | 0.4804 |
| Operating PE Ratio | 11.47 |
| Normalized PE Ratio | 13.84 |